- Treating Burkitt Lymphoma in AdultsCarla Casulo
Wilmot Cancer Institute, University of Rochester, Rochester, NY, USA
Curr Hematol Malig Rep 10:266-71. 2015..Most Burkitt lymphoma patients are cured with intensive treatment; however, prognosis is poor in elderly patients and those with relapsed disease. ..
- A phase I study of PRO131921, a novel anti-CD20 monoclonal antibody in patients with relapsed/refractory CD20+ indolent NHL: correlation between clinical responses and AUC pharmacokineticsCarla Casulo
James P Wilmot Cancer Center, University of Rochester, Rochester, NY, USA Electronic address
Clin Immunol 154:37-46. 2014....
- Tumor associated macrophages in relapsed and refractory Hodgkin lymphomaCarla Casulo
Department of Medicine, University of Rochester, Rochester, NY, USA
Leuk Res 37:1178-83. 2013..However, the impact of TAM in relapsed and refractory disease is unknown...
- 18F-fluorodeoxyglucose positron emission tomography in the staging and prognosis of T cell lymphomaCarla Casulo
Lymphoma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Leuk Lymphoma 54:2163-7. 2013..Interim FDG-PET may predict for PFS. FDG-PET should be integrated into prospective trials to confirm these findings...